- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03694379
Apneic Oxygenation Including Precipitous Intubations During RSI in the ED (RAPID)
March 22, 2020 updated by: Ilya Ostrovsky, MD, Rutgers, The State University of New Jersey
Randomized Controlled Trial of Apneic Oxygenation Including Precipitous Intubations During RSI in the Emergency Department
This RCT is testing the efficacy of apneic oxygenation during endotracheal intubation in the emergency department.
Currently the standard practice in the ED when performing endotracheal intubation is that some providers use apneic oxygenation (the application of a nasal cannula at 15LPM) throughout the intubation procedure, while others do not apply apneic oxygenation.
Initial literature in the operating room showed that apneic oxygenation helps prevent desaturation during the procedure.
However, the latest literature conducted in critical care settings (one study in the ICU and one in the ED) questions the efficacy of this intervention in critically ill patients; however, no harm has been shown.
Our study aims to test this intervention further by adding in a special subset of patients that was excluded from prior studies, precipitous intubations, or those patients that have to be intubated quickly and cannot have adequate pre-oxygenation.
We hypothesize that apneic oxygenation will be more efficacious in this subset than in the overall ED population.
We will randomize patients requiring endotracheal intubation into intervention (apneic oxygenation) and control (no apneic oxygenation).
We will measure the lowest arterial oxygen saturation from the start of the intubation procedure through 2 minutes after intubation is complete.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Newark, New Jersey, United States, 07103
- University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The inclusion criteria for our study will include patients 18 years or older who require emergent endotracheal intubation utilizing rapid sequence intubation (RSI) in the Emergency Department with first attempt taken by a resident or attending physician working in the emergency department. This includes Emergency Medicine attending physicians and residents as well as non-Emergency Medicine rotators (e.g.., Internal Medicine residents who are rotating through the Emergency Department).
Exclusion Criteria:
- Exclusion criteria include patients who are in cardiac arrest, or if the patient received any positive pressure ventilation (i.e, BPAP, CPAP, BVM) in the emergency department before RSI.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Apneic Oxygenation
Participants receiving apneic oxygenation
|
Providing oxygenation through nasal cannula during the apneic phase of endotracheal intubation.
|
|
No Intervention: No Apneic Oxygenation
Participants not receiving apneic oxygenation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lowest oxygen saturation overall
Time Frame: Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
|
Lowest oxygen saturation between overall control and intervention groups
|
Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lowest oxygen saturation precipitous intubations
Time Frame: Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
|
Lowest oxygen saturation between control and intervention groups that did not receive adequate pre-oxygenation only
|
Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
|
|
Lowest oxygen saturation pre-oxygenation
Time Frame: Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
|
Lowest oxygen saturation between control and intervention groups that did receive
|
Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
|
|
Difference in baseline and final oxygen saturation
Time Frame: Decision to intubate through 2 minutes after completion of endotracheal intubation
|
Decision to intubate through 2 minutes after completion of endotracheal intubation
|
|
|
Difference in oxygen saturation before and after apneic period
Time Frame: Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation
|
Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation
|
|
|
Desaturation
Time Frame: Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation
|
The proportion of patients who desaturate below 90%
|
Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation
|
|
number of attempts
Time Frame: From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
|
number of times laryngoscope is placed into the mouth in an attempt to pass an endotracheal tube
|
From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
|
|
Need for second operator
Time Frame: From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
|
A second physician had to attempt intubation
|
From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
|
|
Need for additional intubating equipment
Time Frame: From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
|
The operator needed to change or add equipment to facilitate intubation
|
From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
|
|
Esophageal intubations
Time Frame: From first attempt at intubation through entire ED stay, approximately 6 hours.
|
The proportion of intubations that resulted in the endotracheal tube being placed in the esophagus
|
From first attempt at intubation through entire ED stay, approximately 6 hours.
|
|
Procedural hypotension
Time Frame: Initiation of neuromuscular blockade to 2 minutes after completion of endotracheal intubation
|
Proportion of became hypotensive at any point during the intubation procedure
|
Initiation of neuromuscular blockade to 2 minutes after completion of endotracheal intubation
|
|
Aspiration
Time Frame: Within 24 hours after intubation procedure was complete
|
Proportion of patients that had evidence of aspiration
|
Within 24 hours after intubation procedure was complete
|
|
Hospital length of stay
Time Frame: Up to 28 days after intubation
|
Number of days patient is hospitalized
|
Up to 28 days after intubation
|
|
Number of days intubated
Time Frame: Up to 28 days after intubation
|
Up to 28 days after intubation
|
|
|
In-hospital mortality
Time Frame: Up to 28 days after intubation
|
Up to 28 days after intubation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ilya Ostrovsky, MD, Rutgers, The State University of New Jersey
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2019
Primary Completion (Actual)
March 22, 2020
Study Completion (Actual)
March 22, 2020
Study Registration Dates
First Submitted
September 11, 2018
First Submitted That Met QC Criteria
October 1, 2018
First Posted (Actual)
October 3, 2018
Study Record Updates
Last Update Posted (Actual)
March 25, 2020
Last Update Submitted That Met QC Criteria
March 22, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro2018000579
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.